Commentary: An In Silico - In Vitro Pipeline Identifying an HLA-A*02:01⁺ KRAS G12V⁺ Spliced Epitope Candidate for a Broad Tumor-Immune Response in Cancer Patients.

ABSTRACT:

SUBMITTER: Beer I 

PROVIDER: S-EPMC8315040 | biostudies-literature | 2021

REPOSITORIES: biostudies-literature